Workflow
InfuSystem(INFU)
icon
Search documents
InfuSystem(INFU) - 2021 Q2 - Earnings Call Transcript
2021-08-12 17:15
InfuSystem Holdings Inc. (NYSE:INFU) Q2 2021 Results Conference Call August 12, 2021 9:00 AM ET Company Participants Joe Dorame - Investor Relations Rich DiIorio - Chief Executive Officer Carrie Lachance - President and Chief Operating Officer Barry Steele - Chief Financial Officer Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Alex Nowak - Craig-Hallum Capital Group Jim Sidoti - Sidoti & Company Douglas Weiss - DSW Investment Aaron Warwick - ES Capital Operator Good day, and welc ...
InfuSystem(INFU) - 2021 Q1 - Quarterly Report
2021-05-10 21:20
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended March 31, 2021 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number: 001-35020 INFUSYSTEM HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 20-3341405 (State or Oth ...
InfuSystem(INFU) - 2021 Q1 - Earnings Call Transcript
2021-05-09 16:12
InfuSystem Holdings Inc. (NYSE:INFU) Q1 2021 Earnings Conference Call May 6, 2021 9:00 AM ET Company Participants Joe Dorame - Investor Relations Rich DiIorio - Chief Executive Officer Barry Steele - Chief Financial Officer Carrie Lachance - President and Chief Operating Officer Conference Call Participants Trent McCarthy - Craig-Hallum Frank Takkinen - Lake Street Jim Sidoti - Sidoti & Company James Terwilliger - Northland Securities Doug Weiss - DSW Investments Operator Good day, ladies and gentlemen and ...
InfuSystem (INFU) Investor Presentation - Slideshow
2021-03-30 18:00
Enabling Continuity of Care for Patients, From the Clinic to Their Home Investor Presentation March 2021 l (NYSE American: INFU) Forward-Looking Statement / Non-GAAP Measures Forward-Looking Statement Certain statements contained in this presentation are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, such as statements relating to future actions, business plans, objectives and prospec ...
InfuSystem(INFU) - 2020 Q4 - Annual Report
2021-03-22 21:04
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C., 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ☐ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________________ to ___________________ Commission File Number: 001-35020 INFUSYSTEM HOLDINGS, INC. (Exact Name of Registrant as Specified in its Charter) (St ...
InfuSystem(INFU) - 2020 Q4 - Earnings Call Transcript
2021-03-17 17:47
InfuSystem Holdings Inc. (NYSE:INFU) Q4 2020 Results Earnings Conference Call March 17, 2021 9:00 AM ET Company Participants Joe Dorame - Lytham Partners, IR Rich Dilorio - Chief Executive Officer Barry Steele - Chief Financial Officer Carrie Lachance - President and COO Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Alex Nowak - Craig-Hallum Capital Jim Sidoti - Sidoti & Company Aaron Warwick - ES Capital Douglas Weiss - DSW Investment Operator Good day. And welcome to the InfuSys ...
InfuSystem(INFU) - 2020 Q3 - Quarterly Report
2020-11-13 17:28
for the quarterly period ended September 30, 2020 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number: 001-35020 INFUSYSTEM HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 20-3341405 (State or ...
InfuSystem(INFU) - 2020 Q3 - Earnings Call Transcript
2020-11-12 18:44
InfuSystem Holdings Inc. (NYSE:INFU) Q3 2020 Earnings Conference Call November 12, 2020 9:00 AM ET Company Participants Joe Dorame - Managing Partner, Lytham Partners Rich Dilorio - President & Chief Executive Officer Barry Steele - Chief Financial Officer Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Alex Nowak - Craig-Hallum Capital Douglas Weiss - DSW Investment Aaron Warwick - ES Capital Operator Good morning and welcome to the InfuSystem Holdings, Inc. Reports Third Quarter F ...
InfuSystem Holdings Inc (INFU) Investor Presentation - Slideshow
2020-09-18 12:07
Enabling Continuity of Care for Patients, From the Clinic to Their Home Investor Presentation September 2020 l (NYSE American: INFU) Forward-Looking Statement / Non-GAAP Measures Forward-Looking Statement Certain statements contained in this presentation are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, such as statements relating to future actions, business plans, objectives and pro ...
InfuSystem(INFU) - 2020 Q2 - Quarterly Report
2020-08-14 18:33
Table of Contents (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Delaware 20-3341405 (State or Other Jurisdiction of Incorporation or Organization) Commission File Number: 001-35020 INFUSYSTEM HOLDINGS, INC. FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 ...